Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17966040rdf:typepubmed:Citationlld:pubmed
pubmed-article:17966040lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:17966040lifeskim:mentionsumls-concept:C0067033lld:lifeskim
pubmed-article:17966040lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:17966040lifeskim:mentionsumls-concept:C0004358lld:lifeskim
pubmed-article:17966040lifeskim:mentionsumls-concept:C0162847lld:lifeskim
pubmed-article:17966040lifeskim:mentionsumls-concept:C0337184lld:lifeskim
pubmed-article:17966040lifeskim:mentionsumls-concept:C0185111lld:lifeskim
pubmed-article:17966040lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:17966040pubmed:issue7lld:pubmed
pubmed-article:17966040pubmed:dateCreated2007-10-29lld:pubmed
pubmed-article:17966040pubmed:abstractTextProteinase 3 (PR3)-specific antineutrophil cytoplasmic autoantibodies (PR3-ANCA) recognize conformational epitopes on PR3. This study evaluates PR3-ANCA target epitopes utilizing a novel recombinant PR3 (rPR3) produced to accommodate manipulations of the N-terminal domain. The rPR3 molecule contains an N-terminus six histidine tag, which can be removed by enterokinase (EK) cleavage of an adjacent EK cleavage site. Once cleaved the remaining amino acids correspond to the mature N-terminus of PR3. This rPR3 can be manipulated to produce three variant forms: tagged rPR3(+his), EK-cleaved (his-tag removed) rPR3(- his), and EK-cleaved, denatured/refolded rPR3(- his/dr) (the proteolytically active form). Patients with clinically positive PR3-ANCA titers (n = 40) were confirmed for reactivity against purchased native PR3 in our system. Controls included 29 healthy volunteers and 34 MPO-ANCA patients. All PR3-ANCA sera samples tested were reactive with one or more forms of the recombinant protein (greater than mean ELISA OD 405 + 2 SDs of controls). Of significance, three sera were reactive with non-active forms only and three others were more reactive with rPR3(- his/dr) than with native PR3. The results of our evaluation of PR3-ANCA sera for reactivity against the three forms of our rPR3 protein uniquely exemplify the diverse array of epitopes within the PR3-ANCA population. This new recombinant form of PR3 should provide a suitable approach to mapping ANCA epitopes using site-directed mutagenesis.lld:pubmed
pubmed-article:17966040pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17966040pubmed:languageenglld:pubmed
pubmed-article:17966040pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17966040pubmed:citationSubsetIMlld:pubmed
pubmed-article:17966040pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17966040pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17966040pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17966040pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17966040pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17966040pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17966040pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17966040pubmed:statusMEDLINElld:pubmed
pubmed-article:17966040pubmed:monthNovlld:pubmed
pubmed-article:17966040pubmed:issn1607-842Xlld:pubmed
pubmed-article:17966040pubmed:authorpubmed-author:YangJ JJJlld:pubmed
pubmed-article:17966040pubmed:authorpubmed-author:FalkRonald...lld:pubmed
pubmed-article:17966040pubmed:authorpubmed-author:JennetteJ...lld:pubmed
pubmed-article:17966040pubmed:authorpubmed-author:PrestonGloria...lld:pubmed
pubmed-article:17966040pubmed:authorpubmed-author:PendergraftWi...lld:pubmed
pubmed-article:17966040pubmed:authorpubmed-author:FarragLilaLlld:pubmed
pubmed-article:17966040pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17966040pubmed:volume40lld:pubmed
pubmed-article:17966040pubmed:ownerNLMlld:pubmed
pubmed-article:17966040pubmed:authorsCompleteYlld:pubmed
pubmed-article:17966040pubmed:pagination503-11lld:pubmed
pubmed-article:17966040pubmed:meshHeadingpubmed-meshheading:17966040...lld:pubmed
pubmed-article:17966040pubmed:meshHeadingpubmed-meshheading:17966040...lld:pubmed
pubmed-article:17966040pubmed:meshHeadingpubmed-meshheading:17966040...lld:pubmed
pubmed-article:17966040pubmed:meshHeadingpubmed-meshheading:17966040...lld:pubmed
pubmed-article:17966040pubmed:meshHeadingpubmed-meshheading:17966040...lld:pubmed
pubmed-article:17966040pubmed:meshHeadingpubmed-meshheading:17966040...lld:pubmed
pubmed-article:17966040pubmed:meshHeadingpubmed-meshheading:17966040...lld:pubmed
pubmed-article:17966040pubmed:meshHeadingpubmed-meshheading:17966040...lld:pubmed
pubmed-article:17966040pubmed:meshHeadingpubmed-meshheading:17966040...lld:pubmed
pubmed-article:17966040pubmed:meshHeadingpubmed-meshheading:17966040...lld:pubmed
pubmed-article:17966040pubmed:meshHeadingpubmed-meshheading:17966040...lld:pubmed
pubmed-article:17966040pubmed:meshHeadingpubmed-meshheading:17966040...lld:pubmed
pubmed-article:17966040pubmed:meshHeadingpubmed-meshheading:17966040...lld:pubmed
pubmed-article:17966040pubmed:meshHeadingpubmed-meshheading:17966040...lld:pubmed
pubmed-article:17966040pubmed:year2007lld:pubmed
pubmed-article:17966040pubmed:articleTitleA study of conformational restraints on reactivity of human PR3-specific autoantibodies (ANCA) facilitated through protein folding manipulations of a new recombinant proteinase 3 protein.lld:pubmed
pubmed-article:17966040pubmed:affiliationUNC Kidney Center, University of North Carolina at Chapel Hill, NC 27599, USA.lld:pubmed
pubmed-article:17966040pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17966040pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17966040pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17966040lld:pubmed